Translational Science and Therapeutics Division, Fred Hutch
Dr. Vivian Oehler is a hematologic oncologist who cares for patients with leukemia and other blood disorders. Her research explores the genetic origins and drivers of those diseases. Dr. Oehler also studies why some patients don't respond to the standard treatment for leukemia, a class of targeted cancer drugs called tyrosine kinase inhibitors. These drugs block chemical messengers that help send growth signals in cells. A significant minority of patients develop resistance to the therapy, and Dr. Oehler's lab is trying to identify predictive markers for identifying these patients. Her lab also develops and tests new drugs to treat chronic myeloid leukemia CML and acute myeloid leukemia AML.
Associate Professor, Division of Hematology and Oncology
University of Washington School of Medicine
MD, Case Western Reserve University, 1997
BA, Government, Harvard University, 1989
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email firstname.lastname@example.org or call 206.667.2210